Navigating & Successfully Setting Up an Expanded Access Program for an Ultrarare Disease
Time: 3:30 pm
day: Day Two
Details:
• How do you handle an ultrarare disease?
• How do you get drugs into countries without well-defined regulations
• How do you proceed with continuing a drug within this disease post FDA approval in different countries?
